Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 119, doi. 10.1093/bfgp/ely018
- By:
- Publication type:
- Article
Works matching IS 20412649 AND DT 2019 AND VI 18 AND IP 2
Results: 10
1
2
Immunotherapy for gastric cancer: dilemmas and prospect.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 107, doi. 10.1093/bfgp/ely019
- By:
- Publication type:
- Article
3
Immune checkpoints and cancer in the immunogenomics era.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 133, doi. 10.1093/bfgp/ely027
- By:
- Publication type:
- Article
4
Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 147, doi. 10.1093/bfgp/ely029
- By:
- Publication type:
- Article
5
Genomic and epigenomic perspectives of T-cell exhaustion in cancer.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 113, doi. 10.1093/bfgp/ely005
- By:
- Publication type:
- Article
6
Functional genomics in the era of cancer immunotherapy: challenges and clinical implications.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 83, doi. 10.1093/bfgp/elz003
- By:
- Publication type:
- Article
7
Functional genomics: paving the way for more successful cancer immunotherapy.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 86, doi. 10.1093/bfgp/ely017
- By:
- Publication type:
- Article
8
CD8<sup>+</sup> T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 99, doi. 10.1093/bfgp/ely006
- By:
- Publication type:
- Article
9
Cancer immunotherapy for metastasis: past, present and future.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 140, doi. 10.1093/bfgp/ely022
- By:
- Publication type:
- Article
10
The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
- Published in:
- Briefings in Functional Genomics, 2019, v. 18, n. 2, p. 129, doi. 10.1093/bfgp/ely011
- By:
- Publication type:
- Article